- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Chronic severe disabling pain
- Meeting Date: July 2005
Buprenorphine – July 2007
Buprenorphine, transdermal patch, 5 mg, 10 mg and 20 mg (releasing 5 micrograms, 10 micrograms and 20 micrograms per hour respectively), Norspan®, July 2005
Last updated
27 June 2025
